Editorial: Phage therapy: Past, present and future

Frontiers in Microbiology

Volumn 8, Issue JUN, 2017, Pages

  Abedon, Stephen T ^a   García, Pilar ^b   Mullany, Peter ^c   Aminov, Rustam ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Bacterial infection treatment; Bacteriophage therapy; Biocontrol; Biofilms; Immunology; Lysins; Regulation

Indexed keywords

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIOLYSIS; BACTERIOPHAGE; COHORT ANALYSIS; CYSTIC FIBROSIS; CYTOTOXICITY; EDITORIAL; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; IMMUNE RESPONSE; LYSOGENIZATION; PHAGE THERAPY; SKIN INFECTION; URINARY TRACT INFECTION;

EID: 85020524896     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00981     Document Type: Editorial

References (36)

1. Abedon, S. T. (2015). Ecology of anti-biofilm agents I. Antibiotics versus bacteriophages. Pharmaceuticals 8, 525-558. doi: 10.3390/ph8030525
2. Abedon, S. T. (2015). Ecology of anti-biofilm agents II. Bacteriophage exploitation and biocontrol of biofilm bacteria. Pharmaceuticals 8, 559-589. doi: 10.3390/ph8030559
3. Abedon, S. T. (2015). Phage therapy of pulmonary infections. Bacteriophage 5:e1020260. doi: 10.1080/21597081.2015.1020260
4. Abedon, S. T., Thomas-Abedon, C., Thomas, A., and Mazure, H. (2011). Bacteriophage prehistory: is or is not Hankin, 1896, a phage reference? Bacteriophage 1, 174-178. doi: 10.4161/bact.1.3.16591
5. Aminov, R. (2016). History of antimicrobial drug discovery-major classes and health impact. Biochem. Pharmacol. 133, 4-19. doi: 10.1016/j.bcp.2016.10.001
6. Aminov, R., Caplin, J., Chanishvili, N., Coffey, A., Cooper, I., De Vos, D., et al. (2017). Application of bacteriophages. Microbiology Aust. 38, 63-66. doi: 10.1071/MA17029
7. Aminov, R. I. (2010). A brief history of the antibiotic era: lessons learned and challenges for the future. Front. Microbiol. 1:134. doi: 10.3389/fmicb.2010.00134
8. Aminov, R. I. (2013). Biotic acts of antibiotics. Front. Microbiol. 4:241. doi: 10.3389/fmicb.2013.00241
9. Atterbury, R. J. (2009). Bacteriophage biocontrol in animals and meat products. Microb. Biotechnol. 2, 601-612. doi: 10.1111/j.1751-7915.2009.00089.x
10. Bai, J., Kim, Y. T., Ryu, S., and Lee, J. H. (2016). Biocontrol and rapid detection of food-borne pathogens using bacteriophages and endolysins. Front. Microbiol. 7:474. doi: 10.3389/fmicb.2016.00474
11. Cairns, J., Stent, G., and Watson, J. D. (1966). Phage and the Origins of Molecular Biology. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
12. Clark, J., Abedon, S. T., and Hyman, P. (2012). "Phages as therapeutic delivery vehicles". in Bacteriophages in Health and Disease, eds P. Hyman and S. T. Abedon (Wallingford, CT: CABI Press), 86-100
13. Cooper, R. A., Bjarnsholt, T., and Alhede, M. (2014). Biofilms in wounds: a review of present knowledge. J. Wound. Care 23, 570-580. doi: 10.12968/jowc.2014.23.11.570
14. d'Hérelle, F. (1917). Sur un microbe invisible antagoniste des bacilles dysentériques. C. R. Acad. Sci. D 165, 373-375
15. Expert Round Table on Acceptance and Re-Implementation of Bacteriophage Therapy (2016). Silk route to the acceptance and re-implementation of bacteriophage therapy. Biotechnol. J. 11, 595-600. doi: 10.1002/biot.201600023
16. Fischetti, V. A. (2008). Bacteriophage lysins as effective antibacterials. Curr. Opin. Mirobiol. 11, 393-400. doi: 10.1016/j.mib.2008.09.012
17. Fish, R., Kutter, E., Wheat, G., Blasdel, B., Kutateladze, M., and Kuhl, S. (2016). Bacteriophage treatment of intransigent diabetic toe ulcers: a case series. J. Wound Care 25(Suppl. 7), S27-S33. doi: 10.12968/jowc.2016.25.Sup7.S27
18. Fleming, A. (1929). On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Brit. J. Exp. Pathol. 10, 226-236
19. Gilbert, R. A., Ouwerkerk, D., and Klieve, A. V. (2015). "Phage therapy in livestock methane amelioration". in Livestock Production and Climate Change, eds P. K. Malik, R. Bhatta, J. Takahashi, R. A. Kohn, and C. S. Prasad (Oxfordshire: CABI International), 318-335
20. Hyman, P., Atterbury, R., and Barrow, P. (2013). Fleas and smaller fleas: virotherapy for parasite infections. Trends Microbiol. 21, 215-220. doi: 10.1016/j.tim.2013.02.006
21. Kishor, C., Mishra, R. R., Saraf, S. K., Kumar, M., Srivastav, A. K., and Nath, G. (2016). Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model. Indian J. Med. Res. 143, 87-94. doi: 10.4103/0971-5916.178615
22. Kondo, H., Kanematsu, S., and Suzuki, N. (2013). Viruses of the white root rot fungus, Rosellinia necatrix. Adv. Virus Res. 86, 177-214. doi: 10.1016/B978-0-12-394315-6.00007-6
23. Kutter, E. M., Kuhl, S. J., and Abedon, S. T. (2015). Re-establishing a place for phage therapy in western medicine. Future Microbiol. 10, 685-688. doi: 10.2217/fmb.15.28
24. Miedzybrodzki, R., Borysowski, J., Weber-Dabrowska, B., Fortuna, W., Letkiewicz, S., Szufnarowski, K., et al. (2012). Clinical aspects of phage therapy. Adv. Virus Res. 83, 73-121. doi: 10.1016/B978-0-12-394438-2.00003-7
25. Mirzaei, M. K., and Nilsson, A. S. (2015). Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy. PLoS ONE 10:e0118557. doi: 10.1371/journal.pone.0127606
26. Pires, D. P., Oliveira, H., Melo, L. D., Sillankorva, S., and Azeredo, J. (2016). Bacteriophage-encoded depolymerases: their diversity and biotechnological applications. Appl. Microbiol. Biotechnol. 100, 2141-2151. doi: 10.1007/s00253-015-7247-0
27. Rhoads, D. D., Wolcott, R. D., Kuskowski, M. A., Wolcott, B. M., Ward, L. S., and Sulakvelidze, A. (2009). Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J. Wound Care 18, 237-244. doi: 10.12968/jowc.2009.18.6.42801
28. Rose, T., Verbeken, G., Vos, D. D., Merabishvili, M., Vaneechoutte, M., Lavigne, R., et al. (2014). Experimental phage therapy of burn wound infection: difficult first steps. Int. J. Burns Trauma 4, 66-73
29. Ross, A., Ward, S., and Hyman, P. (2016). More is better: selecting for broad host range bacteriophages. Front. Microbiol. 7:1352. doi: 10.3389/fmicb.2016.01352
30. Sarker, S. A., McCallin, S., Barretto, C., Berger, B., Pittet, A. C., Sultana, S., et al. (2012). Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. Virology 434, 222-232. doi: 10.1016/j.virol.2012.09.002
31. Sarker, S. A., Sultana, S., Reuteler, G., Moine, D., Descombes, P., Charton, F., et al. (2016). Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine 4, 124-137. doi: 10.1016/j.ebiom.2015.12.023
32. Speck, P., and Smithyman, A. (2016). Safety and efficacy of phage therapy via the intravenous route. FEMS Microbiol. Lett. 363:fnv242. doi: 10.1093/femsle/fnv242
33. Summers, W. C. (1991). From culture as organisms to organisms as cell: historical origins of bacterial genetics. J. Hist. Biol. 24, 171-190. doi: 10.1007/BF00209428
34. Summers, W. C. (1999). Felix d'Herelle and the Origins of Molecular Biology. New Haven, CT: Yale University Press
35. Veiga-Crespo, P., Ageitos, J. M., Poza, M., and Villa, T. G. (2007). Enzybiotics: a look at the future, recalling the past. J. Pharm. Sci. 96, 1917-1924. doi: 10.1002/jps.20853
36. Wright, A., Hawkins, C. H., Anggård, E. E., and Harper, D. R. (2009). A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin. Otolaryngol. 34, 349-357. doi: 10.1111/j.1749-4486.2009.01973.x